Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus

To describe vascular events during an 8‐year followup in a multicenter systemic lupus erythematosus (SLE) inception cohort and their attribution to atherosclerosis.

[1]  B. Tom,et al.  Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus Erythematosus , 2008, The Journal of Rheumatology.

[2]  I. Bruce,et al.  Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. , 2008, Arthritis and rheumatism.

[3]  I. Bruce,et al.  Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort , 2007, Lupus.

[4]  J. Reveille,et al.  Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) , 2007, Annals of the rheumatic diseases.

[5]  G. Ruiz-Irastorza,et al.  Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus , 2006, Lupus.

[6]  J. Reveille,et al.  Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. , 2004, Arthritis and rheumatism.

[7]  D. Gladman,et al.  Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. , 2003, The Journal of rheumatology.

[8]  D. Gladman,et al.  Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.

[9]  D. Gladman,et al.  The Systemic Lupus International Collaborating Clinics Group - origins and outcomes , 2001, Lupus.

[10]  I. Bruce,et al.  Premature atherosclerosis in systemic lupus erythematosus. , 2000, Rheumatic diseases clinics of North America.

[11]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[12]  D. Gladman,et al.  The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[13]  R. D'Agostino,et al.  Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.

[14]  D. Symmons,et al.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.

[15]  H. Tunstall-Pedoe,et al.  Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.

[16]  M. Petri,et al.  Risk factors for coronary artery disease in patients with systemic lupus erythematosus. , 1992, The American journal of medicine.

[17]  D. Gladman,et al.  Morbidity in systemic lupus erythematosus. , 1987, The Journal of rheumatology. Supplement.

[18]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[19]  M. Urowitz,et al.  The bimodal mortality pattern of systemic lupus erythematosus. , 1976, The American journal of medicine.

[20]  S. Berney.  Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) , 2008 .

[21]  D. Gladman,et al.  Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. , 2007, The Journal of rheumatology.

[22]  L. Kuller,et al.  Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[23]  F. Furini,et al.  IN SYSTEMIC , 2022 .